Navigation Links
New Study Confirms Link Between Pain Pumps and Cartilage Damage -- Searcy Denney Law Firm Investigates Claims
Date:9/22/2008

South Florida law firm Searcy Denney Scarola Barnhart & Shipley PA (Searcy Denney) has stepped up its investigation into claims stemming from the use of pain pumps following a recent study confirming their dangers.

West Palm Beach, FL (PRWEB) September 22, 2008 -- South Florida law firm Searcy Denney Scarola Barnhart & Shipley PA (Searcy Denney) has stepped up its investigation into claims stemming from the use of pain pumps following a recent study confirming their dangers. According to the new study, the medication delivered by these pumps causes significant cartilage damage. This study confirms and explains earlier reports of adverse outcomes associated with pain pump use. The cartilage damage caused by these pumps results in a condition known as Post Arthroscopic Glenohumeral Chondrolysis (PAGCL), which can lead to significant pain, disability, repeat surgery and not infrequently, the necessity for total joint replacement.

Published in the American Journal of Sports Medicine and presented in July 2008 at this year's American Orthopedic Society for Sports Medicine meeting, the in vitro study measured the extent of cartilage damage caused by directly exposing cartilage to various concentrations and amounts of the pain medicines commonly used in these pumps. After seeing compelling evidence of cartilage destruction, the authors concluded the use of some medications should be discontinued. Others were recommended for use in minimal concentrations and for very short periods of time.

This study follows an earlier study finding pain pumps caused severe cartilage damage. Published by the American Journal of Sports Medicine (AJSM), the prior study found a strong association between the use of high volume pain pumps after arthroscopic surgery and a loss of cartilage in the shoulder. Doctors reviewed 177 shoulder cases and found a staggeringly high incidence of PAGCL in only tho
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. UNC study: Parenting can override effect of genes in how babies respond to stress
2. Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
3. Estrogen flooding our rivers, Université de Montréal study
4. Study suggests why heart attack victims do better with social support
5. Iowa State study finds moms beliefs may impact their kids alcohol use
6. Diabetes Spectrum Reports a Study Assessing the i-port(R) Injection Port for Administration of Insulin
7. Penn researchers use honeybee venom toxin to develop a new tool for studying hypertension
8. Mercks odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study
9. Older problem gamblers may face greater suicide risk than younger counterparts, study finds
10. Colds and flu cut by one-third in study of Canadas top cold fighter in vaccinated seniors
11. Study offers new insights into teenagers and anxiety disorders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 In response to a pr...afety Now ," an initiative from the U.S. Anti-Do...ouncil for Responsible Nutrition (CRN), the leadin...ement industry, issued the following statement: ,... CEO: ,, "We share the concerns of Travis Tyg...
(Date:12/2/2009)...vanced cases, study finds , , WEDNESDAY,...s, survival rates for advanced lung cancer patient...ew study has found. , Researchers analyzed data...e 4 non-small cell lung cancer (NSCLC) between 199.... National Cancer Institute,s Surveillance, Epidem...
(Date:12/2/2009)...e remains unclear, researchers say , , W...suggests that enzyme replacement therapy can make ...ry disease, a rare illness that affects the kidney... linked to the lack of an enzyme that helps metabo...cause it boosts the risk for a stroke, heart attac...
(Date:12/2/2009)...., Dec. 2 Researchers f...n blood cancer research at the annual American Soc... December 4-8, 2009. ,, Throughout the ASH con... experts, including Chief Medical Officer Barton K...t Services Hildy Dillon, and Vice President, Resea...
(Date:12/2/2009)... federal government ends nine months of obstructio...Newswire-USNewswire/ -- More than 2,300 healthcare...lities across Southern California will soon vote o...ealthcare Workers (NUHW). ,, A majority of the ...but SEIU delayed the election by filing frivolous ...
Breaking Medicine News(10 mins):Health News:CRN Responds to 'Supplement Safety Now' Initiative 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 3Health News:Gains Made in Lung Cancer Survival 2Health News:Labor Board OKs 2,300 Kaiser Professionals to Quit SEIU and Join National Union of Healthcare Workers 2
...decrease in health care and compensation benefits,...he economy, employers are managing to maintain a b... Employee Benefits Survey released today by,the So...sing more employers to adjust health care and fina...
... York, June 22). The drug tPA is the most effectiv...s, but its safety is limited to use within the fir...ter that, tPA may cause dangerous bleeding in the ...LICR) and the University of Michigan Medical Schoo...
...men are struggling with the health fallout caused ...(HealthDay News) -- Most women don,t need a survey... often sleep-deprived and feel too sluggish to mak...t most -- women acknowledge that they just don,t g...
... residents in Central U.S. recover, others are pre...oding, WASHINGTON, June 21 The American Red Cros...usands of residents in,states across the Midwest c...i River, residents in Missouri and Illinois,brace ...
...sorts myth from fact when it comes to toeing the l...ne 21 (HealthDay News) -- Summer is here, and many... the beach or in the park. But is that a good thin...rsity,s School of Podiatric Medicine, offers this ...
...HI, India, June 20 The United States,has provided...ernmental,organization Save the Children to assist...s Saiha district of India., Shortages have emerge...ided by the United States, Save the,Children will ...
Other Medicine News:Health News:Despite Economic Downturn, Employee Benefits Remain Stable in 2008 2Health News:Leukemia drug could save lives of stroke patients 2Health News:So Much to Do, So Little Sleep 2Health News:So Much to Do, So Little Sleep 3Health News:The American Red Cross Urges Safety in States Affected by Flooding 2Health News:The American Red Cross Urges Safety in States Affected by Flooding 3Health News:Get in Step With Summer Foot Care 2Health News:Get in Step With Summer Foot Care 3
(Date:12/2/2009)..., Dec. 2 TeamHealth Teleradiology ...ion,s largest provider of hospital-based clinical ... to provide teleradiology services for two groups ... signed with UpState Carolina Radiology located in...ology to provide services for the following four h...
(Date:12/2/2009)... Sweden, December 2 DermaGen AB - ... wound healing company "Pergamum" -,today announce...from a,clinical Phase I/IIa study. DermaGen AB is ...atment for atopic dermatitis. Atopic dermatitis is...n and the skin,s weakened barrier,function make pa...
(Date:12/2/2009)... Keryx Biopharmaceuticals....S. Food and Drug Administration (FDA) has granted... the Company,s novel, potentially first-in-class, ...ositide 3-kinase (PI3K)/Akt pathway, for the treat..., The Fast Track program of the FDA is designed ...
Breaking Medicine Technology:TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Aegis Living Chosen as Best Retirement Facility in 2009 Best of 425 magazine 55950 1Aegis Living Chosen as Best Retirement Facility in 2009 Best of 425 magazine 55950 2Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 1Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 2Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 3Video 3A Renowned Health Expert Dra Aliza Teams Up With Baby Looney Tunes To Promote Healthy Happy Babies 55945 4United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 13786 1United Therapeutics Corporation Announces Stock Split To Be Effected as a Stock Dividend 13786 2
...-Apr 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:...udy of Proellex(TM), an oral drug being developed ...y suggests that,treatment with Proellex results in... symptoms associated with uterine,fibroids and is ...ts , This 12 week, double-blind study compared two...
..., 2007,/PRNewswire-FirstCall/ -- Cell Genesys, Inc...second multi-center Phase 2 trial of GVAX,immunoth...ng doses,of the immunotherapy in 80 patients with ...C). Additional follow-up of,the 22 patients who re...mployed in the company,s ongoing Phase 3 program i...
Other Medicine Technology:Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: